Elizabeth Newton, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 79 Swiftwater Rd, Woodsville, NH 03785 Phone: 603-747-3740 |
Kathleen Elaine Lamberton, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 90 Swiftwater Rd, Woodsville, NH 03785 Phone: 603-747-9000 |
Terrie Ann Nelepovitz, REGISTERED NURSE Registered Nurse - General Practice Medicare: Not Enrolled in Medicare Practice Location: 4976 Dartmouth College Hwy, Woodsville, NH 03785 Phone: 603-747-3300 |
Mrs. Christina Grace Olcott, MSN, APRN, PMHNP-BC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 90 Swiftwater Rd, Woodsville, NH 03785 Phone: 603-747-9000 |
News Archive
Recruitment and retention of physicians in all specialties is a national challenge, and it is expected to become even more difficult due to an impending physician shortage. As relative newcomers to the long line of medical specialists, hospitalists pose special challenges. What will convince a hospitalist to join one organization over another? What might prevent a hospitalist from considering a certain assignment?
Researchers at the University of Houston have replicated the genetic mechanism underlying the transformation of benign esophageal cells into a malignant tumor.
A lecture to mark the 25th anniversary of the Wisdom Hospice in Rochester is taking place at the University of Kent's Medway campus on Monday, 5 October.
The first Global PDX Directory for proprietary and open source PDX models is being introduced by Cambridge (UK) based benefit corporation, Repositive, at the American Association for Cancer Research'sInternational Conference, on Molecular Targets and Cancer Therapeutics, hosted in conjunction with the European Organisation for Research and Treatment of Cancer and the National Cancer Institute, in Philadelphia, USA, 26-30 October 2017.
The Institute for OneWorld Health (iOWH) announced a major milestone in the fight against cholera. The Food and Drug Administration (FDA) granted iOWH permission to begin phase 1 trials for iOWH032, a drug to treat secretory diarrhea. This is the first submission of an Investigational New Drug application for a completely new chemical entity by a non-profit of this size to receive such rapid FDA clearance, and it could be the first synthetic drug of its kind for diarrheal diseases.
› Verified 1 days ago